View Post

$30 Million Funding Empowers All-in-One Vaccine Candidate to Tackle Future Coronaviruses

In COVID-19, Latest News by Precision Vaccinations

As of early July 2022, uncertainty persists as SARS-CoV-2 coronavirus mutations continue emerging. According to the World Health Organization, the Omicron BA.x variants are now dominant worldwide.
There is a clear need for strategies to tackle emerging variants and protect populations against potential future threats to human health, says vaccine researchers from the University of Oxford and Caltech.